c-MYC proto-oncogene protein IVD, antibody

This category includes diagnostic tests that use antibodies to detect the presence or levels of the c-MYC protein in clinical samples. These in vitro diagnostic (IVD) devices help identify abnormalities linked to conditions like certain cancers, such as Burkitt lymphoma or chronic lymphocytic leukemia, by measuring MYC expression.

These tests are typically regulated as in vitro diagnostics and may require compliance with standards like ISO 13485 or FDA 21 CFR Part 820. Availability varies by region, with some supplied as kits for laboratory use, while others may be automated systems for high-throughput testing. Always verify local regulatory requirements before use.